140 participants
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-26
- Start Date:
- 2025-07-20
- Completion:
- 2031-10-26
Conditions
- Renal Cell Carcinoma
Interventions
- DRUG
No Results Yet